Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
- DOI
- 10.1016/s0140-6736(02)07873-x
- Published
- 2002 Mar 2
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-02-07873-x,
title = {Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.},
author = {Mallal S and Nolan D and Witt C and Masel G and Martin AM and Moore C and Sayer D and Castley A and Mamotte C and Maxwell D and James I and Christiansen FT},
year = {2002},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(02)07873-x},
url = {https://doi.org/10.1016/s0140-6736(02)07873-x}
}RIS
TY - JOUR TI - Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. AU - Mallal S AU - Nolan D AU - Witt C AU - Masel G AU - Martin AM AU - Moore C AU - Sayer D AU - Castley A AU - Mamotte C AU - Maxwell D AU - James I AU - Christiansen FT PY - 2002 JO - Lancet (London, England) DO - 10.1016/s0140-6736(02)07873-x UR - https://doi.org/10.1016/s0140-6736(02)07873-x ER -
APA
S, M., D, N., C, W., G, M., AM, M., C, M., D, S., A, C., C, M., D, M., I, J., & FT, C. (2002). Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(02)07873-x
Source records
- pubmed · retrieved 2026-11-10T13:17:21.840Z